Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.
Integrated care (IC) involving medication and intensive counseling provides the best opportunity for smoking cessation in the context of lung cancer screening (LCS).
Findings showed a statistically significant reduction in proptosis in the linsitinib 150mg twice daily group, with a proptosis responder rate of 52% at week 24. Topline results were announced from a ...